News & Articles

Hear expert insights on ADC innovations, manufacturing challenges, and the future of precision medicine

New test format enhances commercialisation potential

Successful project delivery of Optimer binders with proven function as vaccine adjuvants

Since 2021, only 14% of rivers in England achieved ‘good’ ecological status and none received an overall ‘good’ classification from the Environment Agency

Dr. Murakami discusses the molecular tools enabling the pursuit of precision medicine

Technology advances, coupled with collaborations between equipment makers and healthcare organizations, are improving early detection of blood cancers in Africa

Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signalling

The VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment

Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform

Breakthrough status provides expedited review and closer collaboration with the FDA, ultimately enabling broader market reach and commercial adoption

Redipor by AnalytiChem combining 150+ years of expertise in high-quality prepared media, now manufactured in three production facilities worldwide

Agreement represents a significant step towards bringing Sona’s bTB rapid test to the market at scale

Combining Singleron’s innovation in single-cell technologies with Hamilton’s expertise in laboratory automation, Tensor streamlines the single-cell sequencing process

For the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD)

Discover how VIAFLO 96 and VIAFLO 384 handheld electronic pipettes from INTEGRA Biosciences can be used to overcome key challenges associated with cell culture, including contamination, viability, and reproducibility.

Discover how thyroid stimulating immunoglobulin (TSI) testing enhances differentiation of Graves’ disease from other hyperthyroid conditions — enabling precise diagnoses and better patient care

Bruker and RECIPE are pioneering the high-throughput ‘chrom-free’ ClinDART triple-quad MS platform for robust and cost-effective therapeutic drug monitoring assays

New clinical insights reveal how this protein helps diagnose, monitor, and predict flare-ups in rheumatic diseases

Both REQORSA alone and in combination with LUMAKRAS demonstrated robust anti-tumor effects in Ras inhibitor resistant non-small cell lung cancer

As part of LabWeek, Dr. Umama Shahid shares her research on riboswitches and their potential to combat antimicrobial resistance

Innovative 6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from research-scale to commercialization